Candida albicans suppresses nitric oxide (NO) production by interferon- gamma (IFN-γ) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 491-497

  Chinen, T ^a   Qureshi, M H ^a   Koguchi, Y ^a   Kawakami, Kazuyoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Candida albicans; Macrophages; Nitric oxide interferon gamma; Suppression

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL CULTURE; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CANDIDA ALBICANS; FEMALE; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033035316     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00822.x     Document Type: Article

References (52)

1. Odds FC. Candida and candidosis, 2nd edn. London: Baillere-Tindall, 1988.
2. Edwards JE Jr Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone Inc., 1995:2289-306.
3. Domer JE, Lehrer RI. Introduction to candida: systemic candidiasis. In: Murphy JW, Friedman H, Bendinelli M, eds. Fungal infection and immune response. New York: Plenum Press, 1993:49-116.
4. Cantorna M, Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991; 59:2447-55.
5. Bistoni F, Cenci E, Mencacci A, Schaffolla E, Mpsci P, Puccetti P, Romani L. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J Infect Dis 1993; 168:1449-57.
6. Cole GT, Saha K, Seshan KR, Lynn KT, Franco M, Wong PK. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun 1992; 60:4168-78.
7. Romani L, Mocci S, Bietta C, Lanfoloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1991; 59:4647-54.
8. Romani L, Mencacci A, Cenci E, Spaccapelo R, Mosci P, Puccetti P, Bistoni F. CD4+ subset expression in murine candidiasis: Th responses correlate directly with genetically determined susceptibility or vaccine-resistance. J Immunol 1993; 150:925-31.
9. Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Wolf SF, Puccetti P, Bistoni F. Interleukin-12 but not interferon-γ production correlate with induction of T helper type I phenotype in murine candidiasis. Eur J Immunol 1994; 22:909-15.
10. Romani L, Mencacci A, Tonnetti R, Spaccapelo R, Cenci E, Puccetti P, Wolf SF, Bistoni F. IL-12 is both required and prognostic in vivo for T helper type-I differentiation in murine candidiasis. J Immunol 1994; 152:5167-75.
11. Romani L, Cenci E, Mencacci A, Spaccapelo R, Grohmann U, Puccetti P, Bistoni F. Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun 1992; 60:4950-2.
12. Denis M. Interferon-gamma-treated macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 1991; 132:150-7.
13. Granger DL, Hibbs JB Jr, Prefect JR, Durack DT. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest 1990; 85:264-7.
14. Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 1990; 144:4794-7.
15. Langermans JAM, van der Hulst MEB, Nibbering PH, Hiemstra PS, Fransen L, van Furth R. IFN-γ-induced L-arginine-dependent toxoplasmatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J Immunol 1992; 148:568-74.
16. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 1992; 22:2501-6.
17. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with C. Albicans. J Immunol 1994; 152:3514-21.
18. Cenci E, Romani L, Mencacci A, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993; 23:1034-8.
19. Vazquez-Torres A, Jones-Carson J, Balish E. Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice. J Infect Dis 1994; 170:180-8.
20. Horwitz MA. Intracellular parasitism. Curr Opin Immunol 1988; 1:41-46.
21. Clemens DL. Characterization of the Mycobacterium tuberculosis phagosome. Trends Microbiol 1996; 4:113-8.
22. Gordon AH, Hart PD, Young MR. Ammonia inhibits phagosomelysosome fusion in macrophages. Nature 1980; 286:79-80.
23. Goren MB, D'Arey-Hart P, Young MR, Armstrong JA. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1976; 73:2510-4.
24. Horwitz MA. The Legionnaires' disease bacterium (Legionelia pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J Exp Med 1983; 158:2108-26.
25. de Chastellier C, Berche P. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect Immun 1994; 62:543-53.
26. Ley V, Robbins ES, Nussenzweig V, Andrews NW. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J Exp Med 1990; 171:401-13.
27. Kawakami K, Zhang T, Qureshi MH, Saito A. Cryptococcus neoformans inhibit nitric oxide production by murine peritoneal macrophages stimulated with interferon-γ and lipopolysaccharide. Cell Immunol 1997; 180:47-54.
28. Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophagcs. Biochem Biophys Res Commun 1992; 182:1155-9.
29. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992; 148:1792-6.
30. Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hsieh CM, Kourembanas S, Lee ME. Transforming growth factor-β1, but not dexamethasone, down-regulates nitric oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem 1994; 269:14595-600.
31. Pfeilschifter J, Vosbeck K. Transforming growth factor β2 inhibits interleukin-1β- and tumor necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 1991; 175:372-9.
32. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Mod 1989; 169:1543-55.
33. Kawakami K, Tohyama M, Xie Q, Satin A. Expression of cytokine and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun 1997; 65:1307-12.
34. Abrams JS, Roncarolo MG, Yssel H, Anderson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992; 127:5-24.
35. Ayala A, Meldrum DR, Perrin MM. The release of transforming growth factor-β (TGF-β) following hemorrhage (HEM): its roles as a mediator of host immunosuppression. FASEB J 1992; 6:A1604.
36. Louria DB, Brayton RG. Behavior of Candida cells within leukocytes. Proc Soc Exp Biol Med 1964; 115:93-98.
37. Bogdan C, Paik J, Vodovotz Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 1992; 267:23301-8.
38. Reinhold D, Bank U, Buhling F, Lendeckel U, Ulmer AJ, Flad HD, Ansorge S. Transforming growth factor-betal (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 1994; 6:382-8.
39. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
40. Wang P, Wu P, Siegel MI, Wgan RW, Billah MM. IL-10 inhibits transcription of cytokine gene in human peripheral blood mononuclear cells. J Immunol 1994; 153:811-6.
41. Hilger AE, Danley DL. Alteration of polymorphonuclear leukocyte activity by viable Candida albicans. Infect Immun 1980; 27:714-20.
42. Danley DL, Higler AE, Winkel CA. Generation of hydrogen peroxide by Candida albicans and influence on murine polymorphonuclear leukocyte activity. Infect Immun 1983; 40:97-102.
43. Smail EH, Melnick DA, Ruggeri R, Diamond RD. A novel natural inhibitor from Candida albicans hyphae causing dissociation of the neutrophil respiratory burst response to chemotactic peptides from other post-activating events. J Immunol 1988; 140:3893-9.
44. Smail EH, Kolotila MP, Ruggeri R, Diamond RD. Natural inhibitor from Candida albicans blocks release of azurophil and specific granule contents by chemotactic peptide-stimulated human neutrophils. Infect Immun 1989; 57:689-92.
45. Diamond RD, Krzesicki R, Jao W. Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest 1978; 61:349-59.
46. Diamond RD, Oppenheim F, Nakagawa Y, Krzesicki R, Haudenschild CC. Properties of a product of Candida albicans hyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro. J Immunol 1980; 125:2797-804.
47. Piccolella E, Lombardi G, Morelli R. Generation of suppressor cells in the response of human leukocytes to a polysaccharide from Candida albicans. J Immunol 1981; 126:2151-9.
48. Rivas V, Rogers TJ. Studies on the cellular nature of Candida albicans-induced suppression. J Immunol 1983; 130:376-9.
49. Cuff CF, Rogers CM, Lamb BJ, Rogers TJ. Induction of suppressor cells in vitro by Candida albicans. Cell Immunol 1986; 100:47-56.
50. Nelson RD, Herron MJ, McCormack RT. Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide. Infect Immun 1984; 43:1041-6.
51. Podzorski RP, Gray GR, Nelson RD. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol 1990; 144:707-16.
52. Cuff CF, Packer BJ, Rogers TJ. A further characterization of Candida albicans-induced suppressor B-cell activity. Immunol 1989; 68:80-86.